Clinical trial methodology:
Saved in:
| Main Author: | |
|---|---|
| Format: | Electronic eBook |
| Language: | English |
| Published: |
Boca Raton
Chapman and Hall/CRC Press
c2011
|
| Series: | Chapman & Hall/CRC biostatistics series
35 |
| Subjects: | |
| Online Access: | TUM01 Volltext |
| Item Description: | Includes bibliographical references and index 1 - Overview of clinical trial methodology -- - 2 - Overview of the drug development process and regulation of clinical trials -- - 3 - Ethical considerations in the design and conduct of clinical trials -- - 4 - Sample size considerations in clinical trials pre-market approval -- - 5 - Sequential, group sequential, stochastic curtailment, and adaptive design procedures in clinical trials -- - 6 - Biostatistical aspects of the protocol -- - 7 - The statistical analysis plan -- - 8 - Pooling of data from multicenter clinical trials -- - 9 - Validity of statistical inference -- - 10 - Bioequivalence clinical trials -- - 11 - Dose and frequency determination from phase II clinical trials in stress test-induced angina -- - 12 - Confirmation of clinically optimal dosing in the treatment of duodenal ulcers: a phase III dose comparison trial -- - 13 - Pivotal proof-of-efficacy clinical trials in the prevention of NANSAID-induced gastric ulceration -- - 14 - Clinical trials in the treatment of Alzheimer's disease based upon enrichment designs -- - 15 - A clinical trial to establish reduction of CHD risk -- - 16 - Pivotal proof-of-efficacy clinical trials in the treatment of panic disorder -- - 17 - Combination clinical trials -- - 18 - Monitoring clinical trials for adverse events |
| Physical Description: | 1 Online-Ressource (xxv, 394 p.) |
| ISBN: | 1584889179 1584889187 9781584889175 9781584889182 |
Staff View
MARC
| LEADER | 00000nmm a2200000zcb4500 | ||
|---|---|---|---|
| 001 | BV040473136 | ||
| 003 | DE-604 | ||
| 005 | 20130108 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 121011s2011 |||| o||u| ||||||eng d | ||
| 020 | |a 1584889179 |9 1-58488-917-9 | ||
| 020 | |a 1584889187 |c electronic bk. |9 1-58488-918-7 | ||
| 020 | |a 9781584889175 |9 978-1-58488-917-5 | ||
| 020 | |a 9781584889182 |c electronic bk. |9 978-1-58488-918-2 | ||
| 035 | |a (OCoLC)741545900 | ||
| 035 | |a (DE-599)BVBBV040473136 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-91 | ||
| 100 | 1 | |a Peace, Karl E. |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Clinical trial methodology |c Karl E. Peace, Ding-Geng (Din) Chen |
| 264 | 1 | |a Boca Raton |b Chapman and Hall/CRC Press |c c2011 | |
| 300 | |a 1 Online-Ressource (xxv, 394 p.) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 1 | |a Chapman & Hall/CRC biostatistics series |v 35 | |
| 500 | |a Includes bibliographical references and index | ||
| 500 | |a 1 - Overview of clinical trial methodology -- - 2 - Overview of the drug development process and regulation of clinical trials -- - 3 - Ethical considerations in the design and conduct of clinical trials -- - 4 - Sample size considerations in clinical trials pre-market approval -- - 5 - Sequential, group sequential, stochastic curtailment, and adaptive design procedures in clinical trials -- - 6 - Biostatistical aspects of the protocol -- - 7 - The statistical analysis plan -- - 8 - Pooling of data from multicenter clinical trials -- - 9 - Validity of statistical inference -- - 10 - Bioequivalence clinical trials -- - 11 - Dose and frequency determination from phase II clinical trials in stress test-induced angina -- - 12 - Confirmation of clinically optimal dosing in the treatment of duodenal ulcers: a phase III dose comparison trial -- - 13 - Pivotal proof-of-efficacy clinical trials in the prevention of NANSAID-induced gastric ulceration -- - 14 - Clinical trials in the treatment of Alzheimer's disease based upon enrichment designs -- - 15 - A clinical trial to establish reduction of CHD risk -- - 16 - Pivotal proof-of-efficacy clinical trials in the treatment of panic disorder -- - 17 - Combination clinical trials -- - 18 - Monitoring clinical trials for adverse events | ||
| 650 | 4 | |a Clinical trials | |
| 650 | 4 | |a Drugs / Testing | |
| 650 | 4 | |a Clinical Trials as Topic / methods | |
| 650 | 4 | |a Drug Approval / methods | |
| 650 | 4 | |a Drug Evaluation / methods | |
| 650 | 4 | |a Meta-Analysis as Topic | |
| 700 | 1 | |a Chen, Ding-Geng |e Sonstige |4 oth | |
| 830 | 0 | |a Chapman & Hall/CRC biostatistics series |v 35 |w (DE-604)BV023097394 |9 35 | |
| 856 | 4 | 0 | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=342618 |x Verlag |3 Volltext |
| 912 | |a ZDB-4-NLEBK | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-025320425 | ||
| 966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=342618 |l TUM01 |p ZDB-4-NLEBK |q TUM_PDA_EBSCO_MED_gekauft |x Verlag |3 Volltext | |
Record in the Search Index
| _version_ | 1804149536695779328 |
|---|---|
| any_adam_object | |
| author | Peace, Karl E. |
| author_facet | Peace, Karl E. |
| author_role | aut |
| author_sort | Peace, Karl E. |
| author_variant | k e p ke kep |
| building | Verbundindex |
| bvnumber | BV040473136 |
| collection | ZDB-4-NLEBK |
| ctrlnum | (OCoLC)741545900 (DE-599)BVBBV040473136 |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03045nmm a2200457zcb4500</leader><controlfield tag="001">BV040473136</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20130108 </controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">121011s2011 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1584889179</subfield><subfield code="9">1-58488-917-9</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1584889187</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">1-58488-918-7</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781584889175</subfield><subfield code="9">978-1-58488-917-5</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781584889182</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">978-1-58488-918-2</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)741545900</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV040473136</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-91</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Peace, Karl E.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Clinical trial methodology</subfield><subfield code="c">Karl E. Peace, Ding-Geng (Din) Chen</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Boca Raton</subfield><subfield code="b">Chapman and Hall/CRC Press</subfield><subfield code="c">c2011</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (xxv, 394 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Chapman & Hall/CRC biostatistics series</subfield><subfield code="v">35</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">1 - Overview of clinical trial methodology -- - 2 - Overview of the drug development process and regulation of clinical trials -- - 3 - Ethical considerations in the design and conduct of clinical trials -- - 4 - Sample size considerations in clinical trials pre-market approval -- - 5 - Sequential, group sequential, stochastic curtailment, and adaptive design procedures in clinical trials -- - 6 - Biostatistical aspects of the protocol -- - 7 - The statistical analysis plan -- - 8 - Pooling of data from multicenter clinical trials -- - 9 - Validity of statistical inference -- - 10 - Bioequivalence clinical trials -- - 11 - Dose and frequency determination from phase II clinical trials in stress test-induced angina -- - 12 - Confirmation of clinically optimal dosing in the treatment of duodenal ulcers: a phase III dose comparison trial -- - 13 - Pivotal proof-of-efficacy clinical trials in the prevention of NANSAID-induced gastric ulceration -- - 14 - Clinical trials in the treatment of Alzheimer's disease based upon enrichment designs -- - 15 - A clinical trial to establish reduction of CHD risk -- - 16 - Pivotal proof-of-efficacy clinical trials in the treatment of panic disorder -- - 17 - Combination clinical trials -- - 18 - Monitoring clinical trials for adverse events</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Clinical trials</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs / Testing</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Clinical Trials as Topic / methods</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Approval / methods</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Evaluation / methods</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Meta-Analysis as Topic</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Chen, Ding-Geng</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Chapman & Hall/CRC biostatistics series</subfield><subfield code="v">35</subfield><subfield code="w">(DE-604)BV023097394</subfield><subfield code="9">35</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=342618</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-NLEBK</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-025320425</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=342618</subfield><subfield code="l">TUM01</subfield><subfield code="p">ZDB-4-NLEBK</subfield><subfield code="q">TUM_PDA_EBSCO_MED_gekauft</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV040473136 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T00:24:36Z |
| institution | BVB |
| isbn | 1584889179 1584889187 9781584889175 9781584889182 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-025320425 |
| oclc_num | 741545900 |
| open_access_boolean | |
| owner | DE-91 DE-BY-TUM |
| owner_facet | DE-91 DE-BY-TUM |
| physical | 1 Online-Ressource (xxv, 394 p.) |
| psigel | ZDB-4-NLEBK ZDB-4-NLEBK TUM_PDA_EBSCO_MED_gekauft |
| publishDate | 2011 |
| publishDateSearch | 2011 |
| publishDateSort | 2011 |
| publisher | Chapman and Hall/CRC Press |
| record_format | marc |
| series | Chapman & Hall/CRC biostatistics series |
| series2 | Chapman & Hall/CRC biostatistics series |
| spelling | Peace, Karl E. Verfasser aut Clinical trial methodology Karl E. Peace, Ding-Geng (Din) Chen Boca Raton Chapman and Hall/CRC Press c2011 1 Online-Ressource (xxv, 394 p.) txt rdacontent c rdamedia cr rdacarrier Chapman & Hall/CRC biostatistics series 35 Includes bibliographical references and index 1 - Overview of clinical trial methodology -- - 2 - Overview of the drug development process and regulation of clinical trials -- - 3 - Ethical considerations in the design and conduct of clinical trials -- - 4 - Sample size considerations in clinical trials pre-market approval -- - 5 - Sequential, group sequential, stochastic curtailment, and adaptive design procedures in clinical trials -- - 6 - Biostatistical aspects of the protocol -- - 7 - The statistical analysis plan -- - 8 - Pooling of data from multicenter clinical trials -- - 9 - Validity of statistical inference -- - 10 - Bioequivalence clinical trials -- - 11 - Dose and frequency determination from phase II clinical trials in stress test-induced angina -- - 12 - Confirmation of clinically optimal dosing in the treatment of duodenal ulcers: a phase III dose comparison trial -- - 13 - Pivotal proof-of-efficacy clinical trials in the prevention of NANSAID-induced gastric ulceration -- - 14 - Clinical trials in the treatment of Alzheimer's disease based upon enrichment designs -- - 15 - A clinical trial to establish reduction of CHD risk -- - 16 - Pivotal proof-of-efficacy clinical trials in the treatment of panic disorder -- - 17 - Combination clinical trials -- - 18 - Monitoring clinical trials for adverse events Clinical trials Drugs / Testing Clinical Trials as Topic / methods Drug Approval / methods Drug Evaluation / methods Meta-Analysis as Topic Chen, Ding-Geng Sonstige oth Chapman & Hall/CRC biostatistics series 35 (DE-604)BV023097394 35 http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=342618 Verlag Volltext |
| spellingShingle | Peace, Karl E. Clinical trial methodology Chapman & Hall/CRC biostatistics series Clinical trials Drugs / Testing Clinical Trials as Topic / methods Drug Approval / methods Drug Evaluation / methods Meta-Analysis as Topic |
| title | Clinical trial methodology |
| title_auth | Clinical trial methodology |
| title_exact_search | Clinical trial methodology |
| title_full | Clinical trial methodology Karl E. Peace, Ding-Geng (Din) Chen |
| title_fullStr | Clinical trial methodology Karl E. Peace, Ding-Geng (Din) Chen |
| title_full_unstemmed | Clinical trial methodology Karl E. Peace, Ding-Geng (Din) Chen |
| title_short | Clinical trial methodology |
| title_sort | clinical trial methodology |
| topic | Clinical trials Drugs / Testing Clinical Trials as Topic / methods Drug Approval / methods Drug Evaluation / methods Meta-Analysis as Topic |
| topic_facet | Clinical trials Drugs / Testing Clinical Trials as Topic / methods Drug Approval / methods Drug Evaluation / methods Meta-Analysis as Topic |
| url | http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=342618 |
| volume_link | (DE-604)BV023097394 |
| work_keys_str_mv | AT peacekarle clinicaltrialmethodology AT chendinggeng clinicaltrialmethodology |